Trials / Not Yet Recruiting
Not Yet RecruitingNCT06710899
Vitamin C and Hiprex in rUTI
Does Vitamin C Improve the Efficacy of Methenamine Hippurate (Hiprex®) in Prophylaxis of Recurrent Urinary Tract Infections? A Proof of Concept Study
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University Hospitals of North Midlands NHS Trust · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methenamine Hippurate 1g BD | Methenamine Hippurate 1g BD for 6 months |
| DRUG | Methenamine Hippurate 1g BD + Vitamin C 1g BD | Methenamine Hippurate 1g BD + Vitamin C 1g BD for 6 months |
Timeline
- Start date
- 2027-01-01
- Primary completion
- 2027-08-01
- Completion
- 2028-01-01
- First posted
- 2024-11-29
- Last updated
- 2026-02-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06710899. Inclusion in this directory is not an endorsement.